Private company

Clever Leaves Holdings Inc.

Canadian pharmaceutical preparations company, incorporated in British Columbia1

In its 2024 annual report the company says: “We are a multi-national operator in the botanical cannabinoid and nutraceutical industries, with operations and investments in Colombia, the United States, and Canada. We are working to develop one of the industry’s leading, low-cost global supply chains with the goal of providing high quality, pharmaceutical grade cannabis and wellness products to customers and patients at competitive prices produced in a sustainable and environmentally friendly manner.”4

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersA11
  • Incorporated inBritish Columbia, Canada2
  • Business addressBodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca, F8 2510172
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Our mission is to innovate in cannabis products and services, from raw materials to finished products, in an environmentally friendly manner and to be an industry-leading global cannabinoid company recognized for our principles, people, and performance while fostering a healthier global community.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

37.6%Gross margin5
-89.5%Operating margin5
-102.8%Net margin5
6.1%Revenue growth, 20235
-73.9%Return on equity5
0.05×Debt to equity5
-$11.5MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue62¢$10.9M
  • Research and development7¢$1.1M
  • Other costs31¢$5.3M
  • Income tax0¢$68.0K

Out of $17.4M in revenue.5 The company lost money this year.

Financial statements

Revenue6785$17.4M in 2023+122% since 2019
0$5.0M$10.0M$15.0M$20.0M2019: $7.8M$7.8M20192020: $12.1M$12.1M2020+55%2021: $15.4M$15.4M2021+27%2022: $16.4M$16.4M2022+7%2023: $17.4M$17.4M2023+6%
Gross profit6785$6.6M in 2023+111% since 2019
0$2.0M$4.0M$6.0M$8.0M2019: $3.1M$3.1M20192020: $7.4M$7.4M2020+139%2021: $6.8M$6.8M2021−8%2022: $7.2M$7.2M2022+6%2023: $6.6M$6.6M2023−9%
Operating income6785-$15.6M in 2023−57% since 2019
-$60.0M-$40.0M-$20.0M02019: -$36.5M-$36.5M20192020: -$28.5M-$28.5M2020−22%2021: -$57.2M-$57.2M2021+101%2022: -$46.9M-$46.9M2022−18%2023: -$15.6M-$15.6M2023−67%
Net income6785-$17.9M in 2023−55% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$39.5M-$39.5M20192020: -$25.9M-$25.9M2020−34%2021: -$45.7M-$45.7M2021+77%2022: -$66.2M-$66.2M2022+45%2023: -$17.9M-$17.9M2023−73%
Fiscal year201820192020202120222023
Revenue$7.8M6$12.1M7$15.4M8$16.4M5$17.4M5
Cost of revenue$4.7M6$4.7M7$8.6M8$9.2M5$10.9M5
Gross profit$3.1M6$7.4M7$6.8M8$7.2M5$6.6M5
Research and development$1.0M7$1.5M8$1.7M5$1.1M5
Operating expenses$64.0M8$54.1M5$22.1M5
Operating income-$36.5M6-$28.5M7-$57.2M8-$46.9M5-$15.6M5
Income before tax-$44.7M8-$44.1M5-$19.7M5
Income tax$06$07$950.0K8-$6.4M5$68.0K5
Net income-$39.5M6-$25.9M7-$45.7M8-$66.2M5-$17.9M5
Earnings per share-$3.347-$1.788-$51.705-$11.425
Earnings per share (diluted)-$3.347-$1.788-$51.705-$11.425
Shares (weighted, basic)25.7M shares81.3M shares51.6M shares5
Shares (weighted, diluted)25.7M shares81.3M shares51.6M shares5

Compare Clever Leaves Holdings Inc. with another company

Corporate structure

Clever Leaves Holdings Inc. sits at the top of its group. 20 entities, 7 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Clever Leaves Holdings Inc.

  • BCM Investimentos Fundo de Investimento Multimercado Credito Privado Investimento no Exterior Filed SC 13D/A on Clever Leaves Holdings Inc., latest May 21, 2024 (2 filings since May 15, 2024)
  • FARALLON CAPITAL MANAGEMENT, L.L.C. Filed SC 13G/A on Clever Leaves Holdings Inc., latest Jan 23, 2024 (3 filings since Feb 14, 2022)
  • Kyle Detwiler Filed SC 13D/A on Clever Leaves Holdings Inc., latest May 23, 2023
  • Schultze Special Purpose Acquisition Sponsor, LLC Filed SC 13D/A on Clever Leaves Holdings Inc., latest Apr 3, 2023 (2 filings since Feb 7, 2022)
  • ETF MANAGERS GROUP, LLC Filed SC 13G/A on Clever Leaves Holdings Inc., latest Feb 14, 2022 (2 filings since Nov 16, 2021)
  • Clever Leaves Holdings Inc. A1
    • 1255096 B.C. Ltd. ("Newco") Subsidiary · British Columbia, Canada
    • Clever Leaves Australia Pvt Ltd Subsidiary · Australia
    • Clever Leaves Germany GmbH Subsidiary · Germany
    • Clever Leaves II Portugal Cultivation SA Subsidiary · Portugal
    • Clever Leaves International, Inc. Subsidiary · British Columbia, Canada
    • Clever Leaves Portugal Unipessoal LDA Subsidiary · Portugal
    • Clever Leaves UK Limited Subsidiary · United Kingdom
    • Clever Leaves US, Inc. ("SAMA") Subsidiary · Delaware, United States
    • Eagle Canada Holdings, Inc. (“Eagle Canada”) Subsidiary · British Columbia, Canada
    • Ecomedics S.A.S. (“Ecomedics”) Subsidiary · Colombia
    • Herbal Brands, Inc. Subsidiary · Delaware, United States
    • Nordschwan Holdings, Inc. Subsidiary · British Columbia, Canada
    • Northern Swan Deutschland Holdings, Inc. Subsidiary · British Columbia, Canada
    • Northern Swan Europe, Inc. Subsidiary · British Columbia, Canada
    • Northern Swan International, Inc. (“NSI”) Subsidiary · British Columbia, Canada
    • Northern Swan Management, Inc. Subsidiary · British Columbia, Canada
    • Northern Swan Portugal Holdings, Inc. Subsidiary · British Columbia, Canada
    • NS Herbal Brands International, Inc. Subsidiary · British Columbia, Canada
    • NS US Holdings, Inc. Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Clever Leaves Holdings Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$21.1M5 Dec 31, 2023$21.1M5 Dec 31, 2022+0.1%
Accumulated depreciation$8.8M5 Dec 31, 2023$7.1M5 Dec 31, 2022+23.5%
Property and equipment, net$12.3M5 Dec 31, 2023$14.0M5 Dec 31, 2022−11.8%
Operating-lease assets (leased space)$829.0K5 Dec 31, 2023$1.3M5 Dec 31, 2022−36.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$6.8M5 Dec 31, 2023$12.4M5 Dec 31, 2022−45.1%
Stakes in other companies (equity method)$05 Dec 31, 2023$5.7M5 Dec 31, 2022−100.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$08 Dec 31, 2022$08 Dec 31, 2021
Intangible assets, net (excluding goodwill)$2.7M5 Dec 31, 2023$3.4M5 Dec 31, 2022−20.9%
Indefinite-lived intangibles (excluding goodwill)$05 Dec 31, 2022$19.0M8 Dec 31, 2021−100.0%
Finite-lived intangibles, gross$7.1M5 Dec 31, 2023$7.1M5 Dec 31, 20220%
Accumulated amortization$4.4M5 Dec 31, 2023$3.7M5 Dec 31, 2022+18.8%
Finite-lived intangibles, net$2.7M5 Dec 31, 2023$3.4M5 Dec 31, 2022−20.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$4.5M5 Dec 31, 2023$8.4M5 Dec 31, 2022−46.6%
Raw materials$1.1M5 Dec 31, 2023$1.2M5 Dec 31, 2022−9.1%

Leadership

Who has led Clever Leaves Holdings Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (9)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • 1255096 B.C. Ltd. ("Newco") British Columbia, Canada3
  • Clever Leaves Australia Pvt Ltd Australia3
  • Clever Leaves Germany GmbH Hamburg, Germany3
  • Clever Leaves II Portugal Cultivation SA Portugal3
  • Clever Leaves International, Inc. British Columbia, Canada3
  • Clever Leaves Portugal Unipessoal LDA Portugal3
  • Clever Leaves UK Limited London, United Kingdom3
  • Clever Leaves US, Inc. ("SAMA") Delaware, United States3
  • Eagle Canada Holdings, Inc. (“Eagle Canada”) British Columbia, Canada3
  • Ecomedics S.A.S. (“Ecomedics”) Bogota, Colombia3
  • Herbal Brands, Inc. Delaware, United States3
  • Herbal Brands, Ltd. London, United Kingdom3
  • NS Herbal Brands International, Inc. British Columbia, Canada3
  • NS US Holdings, Inc. Delaware, United States3
  • Nordschwan Holdings, Inc. British Columbia, Canada3
  • Northern Swan Deutschland Holdings, Inc. British Columbia, Canada3
  • Northern Swan Europe, Inc. British Columbia, Canada3
  • Northern Swan International, Inc. (“NSI”) British Columbia, Canada3
  • Northern Swan Management, Inc. British Columbia, Canada3
  • Northern Swan Portugal Holdings, Inc. British Columbia, Canada3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Apr 26, 20248-K Listing notice or transfer; Regulation FD disclosure23
  2. Apr 17, 20248-K Ended a material agreement24
  3. Apr 1, 20248-K Results of operations25
  4. Mar 27, 20248-K Entered a material agreement; Completed an acquisition or sale26
  5. Feb 1, 20248-K Entered a material agreement27
  6. Dec 20, 20238-K Entered a material agreement28
  7. Nov 9, 20238-K Results of operations29
  8. Oct 23, 20238-K Entered a material agreement30
  9. Aug 24, 20238-K Change to shareholders' rights; Regulation FD disclosure31
  10. Aug 14, 20238-K Results of operations32
  11. Jul 5, 20238-K Entered a material agreement; Completed an acquisition or sale33
  12. Jun 2, 20238-K Executive or director change; Shareholder vote34
  13. Jul 6, 2022New chief executive Andres Fajardo becomes CEO11
  14. Dec 18, 2020New chief executive Kyle Detwiler becomes CEO12

Calendar

When it reported results

  1. Apr 1, 2024Reported quarterly or annual results25
  2. Nov 9, 2023Reported quarterly or annual results29
  3. Aug 14, 2023Reported quarterly or annual results32
  4. May 11, 2023Reported quarterly or annual results35
  5. Mar 30, 2023Reported quarterly or annual results36
  6. Nov 9, 2022Reported quarterly or annual results37
  7. Aug 11, 2022Reported quarterly or annual results38
  8. May 12, 2022Reported quarterly or annual results39

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

180 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 33 major events, 53 insider forms, 10 large holders, 74 other. The latest 20:

  1. May 21, 20243 OWNERSHIP DOCUMENT EDGAR
  2. May 21, 2024SC 13D/A EDGAR
  3. May 16, 202415-12G EDGAR
  4. May 15, 2024SC 13D EDGAR
  5. May 8, 2024EFFECT EDGAR
  6. May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
  7. May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
  8. May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
  9. May 6, 2024POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 EDGAR
  10. May 6, 202425 EDGAR
  11. Apr 26, 20248-K CURRENT REPORT EDGAR
  12. Apr 22, 2024EFFECT EDGAR
  13. Apr 19, 2024AW AMENDMENT WITHDRAWAL EDGAR
  14. Apr 17, 20248-K EDGAR
  15. Apr 16, 2024POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 EDGAR
  16. Apr 15, 2024S-3/A S-3 EDGAR
  17. Apr 1, 202410-K EDGAR
  18. Apr 1, 20248-K EDGAR
  19. Mar 27, 2024424B3 EDGAR
  20. Mar 27, 20248-K EDGAR

The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

31 open-market trades by officers, directors and large owners since October 2021: 0 buys and 31 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 8, 2024Hague Henry R IIIChief Financial OfficerSale170$3.31$563Form 4
Feb 27, 2024Hague Henry R IIIChief Financial OfficerSale411$3.95$1.6KForm 4
Jan 19, 2024Wilches JulianChief Regulatory OfficerSale131$2.88$377Form 4
Jan 19, 2024Fajardo AndresChief Executive OfficerSale1,561$2.88$4.5KForm 4
Dec 20, 2023Wilches JulianChief Regulatory OfficerSale135$2.04$275Form 4
Dec 20, 2023Wilches JulianChief Regulatory OfficerSale135$2.04$275Form 4
Dec 20, 2023Fajardo AndresChief Executive OfficerSale177$2.04$361Form 4
Dec 20, 2023Fajardo AndresChief Executive OfficerSale177$2.04$361Form 4
Jul 18, 2023Hague Henry R IIIChief Financial OfficerSale1,560$0.22$343Form 4
Jul 18, 2023Wilches JulianChief Regulatory OfficerSale813$0.22$179Form 4
Jul 18, 2023Fajardo AndresChief Executive OfficerSale2,938$0.22$646Form 4
Jun 29, 2023Muecke WilliamDirectorSale251$0.21$53Form 4
Jun 29, 2023Julien Gary MDirectorSale251$0.21$53Form 4
Mar 3, 2023Hague Henry R IIIChief Financial OfficerSale5,678$0.37$2.1KForm 4
Feb 24, 2023Hague Henry R IIIChief Financial OfficerSale9,018$0.42$3.8KForm 4
Feb 22, 2023Hague Henry R IIIChief Financial OfficerSale9,728$0.44$4.3KForm 4
Jan 17, 2023Wilches JulianChief Regulatory OfficerSale4,557$0.40$1.8KForm 4
Jan 17, 2023Fajardo AndresChief Executive OfficerSale57,669$0.40$23.1KForm 4
Dec 20, 2022Wilches JulianChief Regulatory OfficerSale3,829$0.34$1.3KForm 4
Dec 20, 2022Fajardo AndresChief Executive OfficerSale5,133$0.34$1.7KForm 4

All 31 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Clever Leaves Holdings Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARClever Leaves Holdings Inc.1
  • CIK0001819615
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inBritish Columbia, Canada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressBodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca, F8 2510171
  • Phone561-634-74301
  • Shares outstanding1,754,795 as of Mar 19, 20245
  • Public float$11.9M as of Jun 30, 20235
  • On EDGAR sinceAug 6, 20201
  • Filings315 in all: 4 (69), 424B3 (45), 8-K (43), 425 (37), 3 (13), EFFECT (12), 10-Q (9), CORRESP (8)1
    All 36 form types

    POS AM (8), UPLOAD (8), SC 13G/A (6), S-8 POS (5), 10-K (4), 4/A (4), DEFA14A (4), S-4/A (4), SC 13D/A (4), 424B5 (3), DEF 14A (3), SC 13D (3), 3/A (2), 8-A12B (2), 8-K/A (2), S-1 (2), S-8 (2), SC 13G (2), SEC STAFF LETTER (2), 10-K/A (1), 15-12G (1), 25 (1), AW (1), CERT (1), DRS (1), S-3 (1), S-3/A (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Apr 1, 2024
    Quarterly report (10-Q) Nov 9, 2023
    Proxy statement (DEF 14A) Apr 18, 2023
    Latest 8-K (8-K) Apr 26, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44